Home > > > > Report Detail

Global Influenza Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Publisher Name :
Date: 19-Oct-2021
No. of pages: 94

The Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Influenza Vaccine size is estimated to be XX million in 2021 from USD 5303.2 million in 2020, with a change of XX% between 2020 and 2021. The global Influenza Vaccine market size is expected to grow at a CAGR of 3.6% for the next five years.

Market segmentation

Influenza Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

- Trivalent Influenza Vaccine

- Quadrivalent Influenza Vaccine

Market segment by Application can be divided into

- For Children (6 months to 3 years)

- For Adults and Children over 3 years

The key market players for global Influenza Vaccine market are listed below:

- CSL

- GSK

- Sanofi Pasteur

- Mylan

- Hulan Bio

- AstraZeneca

- CCBIO

Market segment by Region, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

- South America (Brazil, Argentina, Colombia, and Rest of South America)

- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Influenza Vaccine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Influenza Vaccine, with price, sales, revenue and global market share of Influenza Vaccine from 2019 to 2021.

Chapter 3, the Influenza Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Influenza Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Influenza Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global Influenza Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
1.1 Influenza Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Influenza Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Influenza Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Global Influenza Vaccine Market Size & Forecast
1.4.1 Global Influenza Vaccine Sales in Value (2016-2026))
1.4.2 Global Influenza Vaccine Sales in Volume (2016-2026)
1.4.3 Global Influenza Vaccine Price by Type (2016-2026) & (USD/Doses)
1.5 Global Influenza Vaccine Production Capacity Analysis
1.5.1 Global Influenza Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Influenza Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Influenza Vaccine Market Drivers
1.6.2 Influenza Vaccine Market Restraints
1.6.3 Influenza Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 CSL
2.1.1 CSL Details
2.1.2 CSL Major Business
2.1.3 CSL Influenza Vaccine Product and Services
2.1.4 CSL Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Influenza Vaccine Product and Services
2.2.4 GSK Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Sanofi Pasteur
2.3.1 Sanofi Pasteur Details
2.3.2 Sanofi Pasteur Major Business
2.3.3 Sanofi Pasteur Influenza Vaccine Product and Services
2.3.4 Sanofi Pasteur Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Influenza Vaccine Product and Services
2.4.4 Mylan Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Hulan Bio
2.5.1 Hulan Bio Details
2.5.2 Hulan Bio Major Business
2.5.3 Hulan Bio Influenza Vaccine Product and Services
2.5.4 Hulan Bio Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Influenza Vaccine Product and Services
2.6.4 AstraZeneca Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 CCBIO
2.7.1 CCBIO Details
2.7.2 CCBIO Major Business
2.7.3 CCBIO Influenza Vaccine Product and Services
2.7.4 CCBIO Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Influenza Vaccine Sales by Manufacturer
3.1 Global Influenza Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Influenza Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Influenza Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Influenza Vaccine Manufacturer Market Share
3.4.2 Top 6 Influenza Vaccine Manufacturer Market Share
3.5 Global Influenza Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Influenza Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Influenza Vaccine Market Size by Region
4.1.1 Global Influenza Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Influenza Vaccine Revenue by Region (2016-2026)
4.2 North America Influenza Vaccine Revenue (2016-2026)
4.3 Europe Influenza Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Influenza Vaccine Revenue (2016-2026)
4.5 South America Influenza Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Influenza Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Influenza Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Influenza Vaccine Revenue by Type (2016-2026)
5.3 Global Influenza Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Influenza Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Influenza Vaccine Revenue by Application (2016-2026)
6.3 Global Influenza Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Influenza Vaccine Sales by Type (2016-2026)
7.2 North America Influenza Vaccine Sales by Application (2016-2026)
7.3 North America Influenza Vaccine Market Size by Country
7.3.1 North America Influenza Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Influenza Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Influenza Vaccine Sales by Type (2016-2026)
8.2 Europe Influenza Vaccine Sales by Application (2016-2026)
8.3 Europe Influenza Vaccine Market Size by Country
8.3.1 Europe Influenza Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Influenza Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Influenza Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Influenza Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Influenza Vaccine Market Size by Region
9.3.1 Asia-Pacific Influenza Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Influenza Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Influenza Vaccine Sales by Type (2016-2026)
10.2 South America Influenza Vaccine Sales by Application (2016-2026)
10.3 South America Influenza Vaccine Market Size by Country
10.3.1 South America Influenza Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Influenza Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Influenza Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Influenza Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Influenza Vaccine Market Size by Country
11.3.1 Middle East & Africa Influenza Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Influenza Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Influenza Vaccine Typical Distributors
12.3 Influenza Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Influenza Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Influenza Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. CSL Basic Information, Manufacturing Base and Competitors
Table 4. CSL Major Business
Table 5. CSL Influenza Vaccine Product and Services
Table 6. CSL Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Influenza Vaccine Product and Services
Table 10. GSK Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Pasteur Major Business
Table 13. Sanofi Pasteur Influenza Vaccine Product and Services
Table 14. Sanofi Pasteur Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Mylan Basic Information, Manufacturing Base and Competitors
Table 16. Mylan Major Business
Table 17. Mylan Influenza Vaccine Product and Services
Table 18. Mylan Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Hulan Bio Basic Information, Manufacturing Base and Competitors
Table 20. Hulan Bio Major Business
Table 21. Hulan Bio Influenza Vaccine Product and Services
Table 22. Hulan Bio Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Influenza Vaccine Product and Services
Table 26. AstraZeneca Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. CCBIO Basic Information, Manufacturing Base and Competitors
Table 28. CCBIO Major Business
Table 29. CCBIO Influenza Vaccine Product and Services
Table 30. CCBIO Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Influenza Vaccine Sales by Manufacturer (2019-2021e) & (M Doses)
Table 32. Global Influenza Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Influenza Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Influenza Vaccine Production Capacity by Company, (M Doses): 2020 VS 2021
Table 35. Head Office and Influenza Vaccine Production Site of Key Manufacturer
Table 36. Influenza Vaccine New Entrant and Capacity Expansion Plans
Table 37. Influenza Vaccine Mergers & Acquisitions in the Past Five Years
Table 38. Global Influenza Vaccine Sales by Region (2016-2021e) & (M Doses)
Table 39. Global Influenza Vaccine Sales by Region (2021-2026) & (M Doses)
Table 40. Global Influenza Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 41. Global Influenza Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 42. Global Influenza Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 43. Global Influenza Vaccine Sales by Type (2021-2026) & (M Doses)
Table 44. Global Influenza Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 45. Global Influenza Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 46. Global Influenza Vaccine Price by Type (2016-2021e) & (USD/Doses)
Table 47. Global Influenza Vaccine Price by Type (2021-2026) & (USD/Doses)
Table 48. Global Influenza Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 49. Global Influenza Vaccine Sales by Application (2021-2026) & (M Doses)
Table 50. Global Influenza Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 51. Global Influenza Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 52. Global Influenza Vaccine Price by Application (2016-2021e) & (USD/Doses)
Table 53. Global Influenza Vaccine Price by Application (2021-2026) & (USD/Doses)
Table 54. North America Influenza Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 55. North America Influenza Vaccine Sales by Country (2021-2026) & (M Doses)
Table 56. North America Influenza Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 57. North America Influenza Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 58. North America Influenza Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 59. North America Influenza Vaccine Sales by Type (2021-2026) & (M Doses)
Table 60. North America Influenza Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 61. North America Influenza Vaccine Sales by Application (2021-2026) & (M Doses)
Table 62. Europe Influenza Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 63. Europe Influenza Vaccine Sales by Country (2021-2026) & (M Doses)
Table 64. Europe Influenza Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 65. Europe Influenza Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 66. Europe Influenza Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 67. Europe Influenza Vaccine Sales by Type (2021-2026) & (M Doses)
Table 68. Europe Influenza Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 69. Europe Influenza Vaccine Sales by Application (2021-2026) & (M Doses)
Table 70. Asia-Pacific Influenza Vaccine Sales by Region (2016-2021e) & (M Doses)
Table 71. Asia-Pacific Influenza Vaccine Sales by Region (2021-2026) & (M Doses)
Table 72. Asia-Pacific Influenza Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 73. Asia-Pacific Influenza Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific Influenza Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 75. Asia-Pacific Influenza Vaccine Sales by Type (2021-2026) & (M Doses)
Table 76. Asia-Pacific Influenza Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 77. Asia-Pacific Influenza Vaccine Sales by Application (2021-2026) & (M Doses)
Table 78. South America Influenza Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 79. South America Influenza Vaccine Sales by Country (2021-2026) & (M Doses)
Table 80. South America Influenza Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 81. South America Influenza Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 82. South America Influenza Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 83. South America Influenza Vaccine Sales by Type (2021-2026) & (M Doses)
Table 84. South America Influenza Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 85. South America Influenza Vaccine Sales by Application (2021-2026) & (M Doses)
Table 86. Middle East & Africa Influenza Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 87. Middle East & Africa Influenza Vaccine Sales by Country (2021-2026) & (M Doses)
Table 88. Middle East & Africa Influenza Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 89. Middle East & Africa Influenza Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa Influenza Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 91. Middle East & Africa Influenza Vaccine Sales by Type (2021-2026) & (M Doses)
Table 92. Middle East & Africa Influenza Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 93. Middle East & Africa Influenza Vaccine Sales by Application (2021-2026) & (M Doses)
Table 94. Direct Channel Pros & Cons
Table 95. Indirect Channel Pros & Cons
Table 96. Influenza Vaccine Typical Distributors
Table 97. Influenza Vaccine Typical Customers
List of Figures
Figure 1. Influenza Vaccine Picture
Figure 2. Global Influenza Vaccine Sales Market Share by Type in 2020
Figure 3. Trivalent Influenza Vaccine
Figure 4. Quadrivalent Influenza Vaccine
Figure 5. Global Influenza Vaccine Sales Market Share by Application in 2020
Figure 6. For Children (6 months to 3 years)
Figure 7. For Adults and Children over 3 years
Figure 8. Global Influenza Vaccine Market Size, (USD Million) & (M Doses): 2020 VS 2021 VS 2026
Figure 9. Global Influenza Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Influenza Vaccine Sales (2016-2026) & (M Doses)
Figure 11. Global Influenza Vaccine Price by Type (2016-2026) & (USD/Doses)
Figure 12. Global Influenza Vaccine Production Capacity (2016-2026) & (M Doses)
Figure 13. Global Influenza Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Influenza Vaccine Market Drivers
Figure 15. Influenza Vaccine Market Restraints
Figure 16. Influenza Vaccine Market Trends
Figure 17. Global Influenza Vaccine Sales Market Share by Manufacturer in 2020
Figure 18. Global Influenza Vaccine Revenue Market Share by Manufacturer in 2020
Figure 19. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Influenza Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Influenza Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Influenza Vaccine Sales Market Share by Region (2016-2026)
Figure 23. Global Influenza Vaccine Revenue Market Share by Region (2016-2026)
Figure 24. North America Influenza Vaccine Revenue (2016-2026) & (USD Million)
Figure 25. Europe Influenza Vaccine Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Influenza Vaccine Revenue (2016-2026) & (USD Million)
Figure 27. South America Influenza Vaccine Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Influenza Vaccine Revenue (2016-2026) & (USD Million)
Figure 29. Global Influenza Vaccine Sales Market Share by Type (2016-2026)
Figure 30. Global Influenza Vaccine Revenue Market Share by Type (2016-2026)
Figure 31. Global Influenza Vaccine Price by Type (2016-2026) & (USD/Doses)
Figure 32. Global Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 33. Global Influenza Vaccine Revenue Market Share by Application (2016-2026)
Figure 34. Global Influenza Vaccine Price by Application (2016-2026) & (USD/Doses)
Figure 35. North America Influenza Vaccine Sales Market Share by Type (2016-2026)
Figure 36. North America Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 37. North America Influenza Vaccine Sales Market Share by Country (2016-2026)
Figure 38. North America Influenza Vaccine Revenue Market Share by Country (2016-2026)
Figure 39. United States Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Influenza Vaccine Sales Market Share by Type (2016-2026)
Figure 43. Europe Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 44. Europe Influenza Vaccine Sales Market Share by Country (2016-2026)
Figure 45. Europe Influenza Vaccine Revenue Market Share by Country (2016-2026)
Figure 46. Germany Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Influenza Vaccine Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Influenza Vaccine Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Influenza Vaccine Revenue Market Share by Region (2016-2026)
Figure 55. China Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Influenza Vaccine Sales Market Share by Type (2016-2026)
Figure 62. South America Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 63. South America Influenza Vaccine Sales Market Share by Country (2016-2026)
Figure 64. South America Influenza Vaccine Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Influenza Vaccine Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Influenza Vaccine Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Influenza Vaccine Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Influenza Vaccine Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Influenza Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
  • Global Encephalitis Vaccination Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
  • Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
  • Global Avian Influenza Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
  • Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
  • Global Influenza Vaccine Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......
  • Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......
  • 2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107
    This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs